At what ferritin level should iron supplements be started?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Iron Supplementation Thresholds Based on Ferritin Levels

Iron supplementation should be initiated when serum ferritin levels are below 30 μg/L in individuals without inflammatory conditions, or below 100 μg/L in patients with inflammation or chronic disease. 1

Diagnostic Criteria for Iron Deficiency

The diagnosis of iron deficiency depends on the presence or absence of inflammation:

  • Without inflammation/chronic disease:

    • Serum ferritin < 30 μg/L
    • Transferrin saturation < 16%
    • High Total Iron-Binding Capacity (TIBC) 1
  • With inflammation/chronic disease:

    • Serum ferritin < 100 μg/L
    • Transferrin saturation < 20% 2, 1
    • If ferritin is between 30-100 μg/L with inflammation, a combination of true iron deficiency and anemia of chronic disease is likely 2

Treatment Algorithm

  1. For patients without inflammation or chronic disease:

    • Start oral iron when ferritin < 30 μg/L 1
    • Recommended dose: 60-200 mg elemental iron daily 1
    • Consider adding vitamin C 250-500 mg with iron to enhance absorption 1
  2. For patients with inflammation or chronic disease (IBD, CKD, cancer, etc.):

    • Start iron supplementation when ferritin < 100 μg/L 2, 1
    • For mild anemia with clinically inactive disease: oral iron may be used 2
    • For clinically active disease: intravenous iron should be first-line 2
  3. Special considerations for intravenous iron:

    • Indicated when ferritin < 100 μg/L with:
      • Clinically active inflammatory disease
      • Previous intolerance to oral iron
      • Hemoglobin < 100 g/L
      • Need for erythropoiesis-stimulating agents
      • Malabsorption
      • Ongoing blood loss 2, 1, 3

Monitoring and Treatment Goals

  • Monitor hemoglobin and iron studies after 4 weeks of treatment 1
  • Continue iron therapy for three months after correction of anemia 1
  • Target parameters:
    • Serum ferritin > 100 ng/mL
    • Transferrin saturation > 20%
    • Hemoglobin 11-12 g/dL 1

Important Clinical Considerations

  • Iron deficiency without anemia can cause significant symptoms including fatigue, irritability, depression, difficulty concentrating, and restless legs syndrome 3
  • Long-term daily iron supplementation with normal/high ferritin values is potentially harmful and not recommended 1
  • In chronic kidney disease patients, the 2012 KDIGO guidelines specified ferritin ≤ 500 ng/ml and transferrin saturation ≤ 30% as thresholds for iron parameters 4
  • For heart failure patients with iron deficiency, intravenous iron has shown improvements in symptom status, with iron deficiency defined as ferritin < 100 ng/mL or ferritin 100-300 ng/mL when transferrin saturation < 20% 5

Common Pitfalls to Avoid

  • Focusing solely on hemoglobin without checking iron parameters can miss non-anemic iron deficiency, which still causes significant symptoms 3, 6
  • Interpreting borderline values as abnormal when the overall pattern indicates normal iron status can result in unnecessary interventions 1
  • Failing to adjust ferritin thresholds in the presence of inflammation can lead to missed diagnoses 2, 1
  • Unnecessary vitamin C supplementation with oral iron may not provide additional benefit for iron absorption in all patients 7

By following these evidence-based guidelines for initiating iron supplementation based on ferritin levels, clinicians can effectively manage iron deficiency and improve patient outcomes related to morbidity, mortality, and quality of life.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.